We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Polyplus-transfection Licenses Roche Glycart AG for PEI in vitro Transfection Applications for Research Purposes

News   Jan 24, 2011

 
Polyplus-transfection Licenses Roche Glycart AG for PEI in vitro Transfection Applications for Research Purposes
 
 
 

RELATED ARTICLES

Our Microbiome Is What We Eat

News

A high-quality diet is linked to more potentially beneficial bacteria in the gut; while a low-quality diet is associated with an increase in potentially harmful bacteria. Modifying the microbiome through diet may therefore be part of a strategy to reduce the risk of chronic diseases.

READ MORE

Controlling HIV Infection by Reprogramming Immune Cells

News

Scientists have described the characteristics of CD8 immune cells in "HIV controller" patients and used the information on the unique antiviral power of these immune cells to reprogramme cells from individuals who can't fight the infection.

READ MORE

Enhancing the Infection-fighting Potential of Natural Products

News

A team has identified multiple promising new drug candidates to treat antibiotic-resistant infections, including the superbug MRSA.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE